Ramasastry Saira bought MIRM

September 8, 2025 · Form 4 insider transaction

Ramasastry Saira bought 17,000 shares of Mirum Pharmaceuticals, Inc. at $23.51 per share, a transaction worth $399.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
17,000
Price
$23.51
Total value
$399.7K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 8, 2025
Filing dateSeptember 10, 2025
Shares owned after17,000
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR